From the Guidelines
A sodium level of 119 mEq/L is considered severe hyponatremia and requires immediate attention in an intensive care or monitored setting. This condition can lead to serious neurological symptoms, including confusion, seizures, and coma, and thus necessitates careful management to prevent further complications 1. The primary goal in treating severe hyponatremia is to correct the sodium level at a safe rate to avoid osmotic demyelination syndrome (ODS), with a recommended increase of 4-6 mEq/L per 24-hour period, not to exceed 8 mEq/L per 24-hour period 1.
Management Considerations
- Water restriction to less than 1,000 mL/day is recommended, along with the cessation of diuretics, for the management of moderate to severe hyponatremia 1.
- Hypertonic saline may be used for short-term treatment in patients with symptomatic or severe hyponatremia, or those awaiting liver transplantation (LT) 1.
- Vasopressin receptor antagonists can be considered for short-term use (≤30 days) to raise serum sodium levels, but their use should be cautious 1.
- Albumin infusion may be recommended alongside a more severe restriction of water intake for severe hyponatremia 1.
Clinical Approach
- Frequent monitoring of serum sodium levels is crucial, especially when administering hypertonic saline, to avoid overcorrection 1.
- The underlying cause of hyponatremia must be addressed concurrently with sodium correction, which may involve stopping certain medications, treating the syndrome of inappropriate antidiuretic hormone secretion (SIADH), or managing volume depletion.
- Symptoms such as headache, nausea, confusion, seizures, or decreased consciousness necessitate urgent intervention to prevent progression to more severe neurological damage.
Given the potential for severe complications, including ODS, especially in the context of liver disease and potential liver transplantation, multidisciplinary coordinated care is essential to mitigate these risks 1.
From the FDA Drug Label
5.1 Too Rapid Correction of Serum Sodium Can Cause Serious Neurologic Sequelae Osmotic demyelination syndrome is a risk associated with too rapid correction of hyponatremia (e.g., > 12 mEq/L/24 hours). In controlled clinical trials in which tolvaptan was administered in titrated doses starting at 15 mg once daily, 7% of tolvaptan-treated subjects with a serum sodium <130 mEq/L had an increase in serum sodium greater than 8 mEq/L at approximately 8 hours and 2% had an increase greater than 12 mEq/L at 24 hours Approximately 1% of placebo-treated subjects with a serum sodium <130 mEq/L had a rise greater than 8 mEq/L at 8 hours and no patient had a rise greater than 12 mEq/L/24 hours.
Sodium level of 119 mEq/L requires close monitoring.
- Patients with serum sodium <130 mEq/L are at risk for too-rapid correction of serum sodium.
- Intensive care or monitoring is recommended for patients with severe hyponatremia (sodium <125 mEq/L) to avoid overly rapid correction of serum sodium.
- The rate of correction should be less than 12 mEq/L/24 hours to minimize the risk of osmotic demyelination syndrome.
- Fluid restriction should be avoided during the first 24 hours of therapy to prevent overly rapid correction of serum sodium 2.
From the Research
Sodium Level of 119 mmol/L
- A sodium level of 119 mmol/L is considered hyponatremic, as the normal range for serum sodium is between 135-145 mmol/L 3.
- Hyponatremia can be classified into three categories based on volume status: hypovolemic, euvolemic, and hypervolemic 3, 4.
- The management of hyponatremia depends on the underlying cause, severity of symptoms, and volume status 3, 4.
Need for Intensive Care or Monitoring
- Patients with severe symptomatic hyponatremia, such as those with somnolence, obtundation, coma, seizures, or cardiorespiratory distress, require immediate treatment in an intensive care unit (ICU) 3, 5.
- Hypertonic saline is used to treat severe symptomatic hyponatremia, with the goal of increasing the serum sodium level by 4-6 mmol/L within 1-2 hours, but not exceeding a correction limit of 10 mmol/L within the first 24 hours 3, 6.
- Close monitoring of the patient's mentation, urine output, and serum sodium levels is necessary to avoid overly rapid correction, which can result in neurological injury caused by osmotic demyelination 3, 5.
- In patients with chronic hyponatremia, the correction rate should be sufficient to reduce symptoms but not at an excessive rate that would create a risk of osmotic injury 7, 5.